ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 161 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $17,732,000 | -17.0% | 441,649 | -4.9% | 3.89% | -42.3% |
| Q4 2018 | $21,374,000 | -59.9% | 464,649 | -61.3% | 6.74% | -52.6% |
| Q3 2018 | $53,248,000 | +13.2% | 1,200,100 | 0.0% | 14.21% | +86.0% |
| Q2 2018 | $47,032,000 | +288.0% | 1,200,100 | +616.1% | 7.64% | +55.3% |
| Q1 2018 | $12,121,000 | -16.3% | 167,587 | -42.0% | 4.92% | -42.0% |
| Q4 2017 | $14,490,000 | 0.0% | 289,100 | 0.0% | 8.49% | +12.7% |
| Q3 2017 | $14,490,000 | -7.9% | 289,100 | -15.0% | 7.53% | -24.1% |
| Q2 2017 | $15,740,000 | +31.1% | 340,100 | 0.0% | 9.92% | +77.2% |
| Q1 2017 | $12,009,000 | – | 340,100 | – | 5.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |